Approach to the treatment of hyperuricemia
- PMID: 19999894
Approach to the treatment of hyperuricemia
Similar articles
-
Febuxostat--treatment for hyperuricemia and gout?N Engl J Med. 2005 Dec 8;353(23):2505-7. doi: 10.1056/NEJMe058247. N Engl J Med. 2005. PMID: 16339099 No abstract available.
-
Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.Med Lett Drugs Ther. 2017 Nov 6;59(1533):182-183. Med Lett Drugs Ther. 2017. PMID: 29125593 No abstract available.
-
The current state of care in gout: Addressing the need for better understanding of an ancient disease.J Am Acad Nurse Pract. 2010 Nov;22 Suppl 1:623-36. doi: 10.1111/j.1745-7599.2010.00556.x. Epub 2010 Nov 3. J Am Acad Nurse Pract. 2010. PMID: 21054636
-
Crystal arthropathies: recognizing and treating "the gouch".Prim Care. 2010 Dec;37(4):703-11, v. doi: 10.1016/j.pop.2010.07.008. Prim Care. 2010. PMID: 21050952 Review.
-
Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033. Clin Ther. 2009. PMID: 20109996 Review.
Cited by
-
Biopharmaceutical Study on Nobiletin-Loaded Amorphous Solid Dispersion with Improved Hypouricemic Effect.Molecules. 2021 Jul 23;26(15):4447. doi: 10.3390/molecules26154447. Molecules. 2021. PMID: 34361599 Free PMC article.
-
Dosage individualization proposed for anti-gout medications among the patients with gout.PLoS One. 2021 Sep 17;16(9):e0257082. doi: 10.1371/journal.pone.0257082. eCollection 2021. PLoS One. 2021. PMID: 34534233 Free PMC article.
-
Pharmacotherapy for hyperuricemia in hypertensive patients.Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD008652. doi: 10.1002/14651858.CD008652.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Sep 2;9:CD008652. doi: 10.1002/14651858.CD008652.pub4. PMID: 28406263 Free PMC article. Updated.
-
The development of an effective synthetic route of lesinurad (RDEA594).Chem Cent J. 2017 Sep 5;11(1):86. doi: 10.1186/s13065-017-0316-y. Chem Cent J. 2017. PMID: 29086884 Free PMC article.
-
Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid.iScience. 2022 Sep 28;25(10):105198. doi: 10.1016/j.isci.2022.105198. eCollection 2022 Oct 21. iScience. 2022. PMID: 36248735 Free PMC article.